G M Shaw1, K Todoroff, R H Finnell, E J Lammer. 1. March of Dimes Birth Defects Foundation, California Birth Defects Monitoring Program, Emeryville, California 94608, USA.
Abstract
BACKGROUND: A twofold or greater risk of neural tube defect (NTD)-affected pregnancy has been associated with prepregnant obesity, where obesity was defined as body mass index (BMI) of >29 kg/m(2). Risks have been more elevated for spina bifida than for anencephaly. METHODS: We investigated whether finer phenotypic classifications of spina bifida, in combination with other factors, were associated with a BMI of >29 kg/m(2). Data were derived from a case-control study of fetuses and infants with NTDs among 1989-1991 California births. Interviews were conducted with mothers of 277 spina bifida cases and 517 nonmalformed controls. RESULTS: Women with a BMI of >29 kg/m(2) compared with those </=29 kg/m(2) revealed an odds ratio (OR) of 2.2 (95% confidence interval [95% CI] = 1.4-3. 3) for spina bifida in their infants and fetuses. Elevated risks were observed for each spina bifida subphenotype, and risks varied by subphenotype: open spina bifida, OR = 2.0 (1.2-3.1); closed (skin-covered), 3.3 (1.4-7.5); isolated, 2.2 (1.4-3.4); nonisolated, 1.9 (0.9-4.2); high, 4.5 (2.1-9.6); low, 1.9 (1.2-2.9); open/isolated/high, 7.1 (2.8-18.1); and open/isolated/low, 1.8 (1. 1-3.1). Risks were higher among female infants/fetuses and foreign-born Latinas, and for some phenotypes the risks were quite large, e.g., OR = 8.3 (2.9-23.6) for "closed" spina bifida among female infants/fetuses whose mothers were >29 kg/m(2) compared with males whose mothers were </=29 kg/m(2). Maternal periconceptional vitamin use was not observed to influence risk as greatly across phenotypes. CONCLUSIONS: The observed pathogenetic heterogeneity of prepregnant obesity and spina bifida risks suggests that there are likely to be several biologic mechanisms underlying the association. Copyright 2000 Wiley-Liss, Inc.
BACKGROUND: A twofold or greater risk of neural tube defect (NTD)-affected pregnancy has been associated with prepregnant obesity, where obesity was defined as body mass index (BMI) of >29 kg/m(2). Risks have been more elevated for spina bifida than for anencephaly. METHODS: We investigated whether finer phenotypic classifications of spina bifida, in combination with other factors, were associated with a BMI of >29 kg/m(2). Data were derived from a case-control study of fetuses and infants with NTDs among 1989-1991 California births. Interviews were conducted with mothers of 277 spina bifida cases and 517 nonmalformed controls. RESULTS:Women with a BMI of >29 kg/m(2) compared with those </=29 kg/m(2) revealed an odds ratio (OR) of 2.2 (95% confidence interval [95% CI] = 1.4-3. 3) for spina bifida in their infants and fetuses. Elevated risks were observed for each spina bifida subphenotype, and risks varied by subphenotype: open spina bifida, OR = 2.0 (1.2-3.1); closed (skin-covered), 3.3 (1.4-7.5); isolated, 2.2 (1.4-3.4); nonisolated, 1.9 (0.9-4.2); high, 4.5 (2.1-9.6); low, 1.9 (1.2-2.9); open/isolated/high, 7.1 (2.8-18.1); and open/isolated/low, 1.8 (1. 1-3.1). Risks were higher among female infants/fetuses and foreign-born Latinas, and for some phenotypes the risks were quite large, e.g., OR = 8.3 (2.9-23.6) for "closed" spina bifida among female infants/fetuses whose mothers were >29 kg/m(2) compared with males whose mothers were </=29 kg/m(2). Maternal periconceptional vitamin use was not observed to influence risk as greatly across phenotypes. CONCLUSIONS: The observed pathogenetic heterogeneity of prepregnant obesity and spina bifida risks suggests that there are likely to be several biologic mechanisms underlying the association. Copyright 2000 Wiley-Liss, Inc.
Authors: Philip J Lupo; Laura E Mitchell; Mark A Canfield; Gary M Shaw; Andrew F Olshan; Richard H Finnell; Huiping Zhu Journal: Mol Genet Metab Date: 2013-11-18 Impact factor: 4.797
Authors: Yvonne W Wu; Lisa A Croen; Louis Henning; Daniel V Najjar; Michael Schembri; Mary S Croughan Journal: Birth Defects Res A Clin Mol Teratol Date: 2006-10
Authors: Philip J Lupo; Mark A Canfield; Claudia Chapa; Wei Lu; A J Agopian; Laura E Mitchell; Gary M Shaw; D Kim Waller; Andrew F Olshan; Richard H Finnell; Huiping Zhu Journal: Am J Epidemiol Date: 2012-11-06 Impact factor: 4.897
Authors: Marloes Dekker Nitert; Katie F Foxcroft; Karin Lust; Narelle Fagermo; Debbie A Lawlor; Michael O'Callaghan; H David McIntyre; Leonie K Callaway Journal: BMC Pregnancy Childbirth Date: 2011-11-21 Impact factor: 3.007
Authors: Maitreyi Mazumdar; Md Omar Sharif Ibne Hasan; Rezina Hamid; Linda Valeri; Ligi Paul; Jacob Selhub; Ema G Rodrigues; Fareesa Silva; Selim Mia; Md Golam Mostofa; Quazi Quamruzzaman; Mahmuder Rahman; David C Christiani Journal: Environ Health Date: 2015-04-10 Impact factor: 5.984